{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:33:32Z","timestamp":1790674412911,"version":"4.1.0"},"reference-count":52,"publisher":"China Science Publishing & Media Ltd.","issue":"3","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2012,3,1]]},"DOI":"10.1093\/abbs\/gmr125","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T01:54:19Z","timestamp":1326246859000},"page":"249-258","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Truncated N-terminal huntingtin fragment with expanded-polyglutamine (htt552-100Q) suppresses brain-derived neurotrophic factor transcription in astrocytes"],"prefix":"10.3724","volume":"44","author":[{"given":"Linhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"DiFiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","year":"1993","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 1993, 72: 971-983.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","volume":"63","author":"Borrell-Pag\u00e8s M","year":"2006","unstructured":"Borrell-Pag\u00e8s M, Zala D, Humbert S, Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci, 2006, 63: 2642-2660.","journal-title":"Cell Mol Life Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/MN:23:1:21","volume":"23","author":"Sipione S","year":"2001","unstructured":"Sipione S, Cattaneo E. Modeling Huntington's disease in cells, flies and mice. Mol Neurobiol, 2001, 23: 21-51.","journal-title":"Mol Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","volume":"13","author":"Goldberg YP","year":"1996","unstructured":"Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet, 1996, 13: 442-449.","journal-title":"Nat Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"Wellington CL","year":"1998","unstructured":"Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem, 1998, 273: 9158-9167.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","volume":"275","author":"Wellington CL","year":"2000","unstructured":"Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, Cattaneo E. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem, 2000, 275: 19831-19838.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"Gafni J","year":"2002","unstructured":"Gafni J, Ellerby LM. Calpain activation in Huntington's disease. J Neurosci, 2002, 22: 4842-4849.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","volume":"279","author":"Gafni J","year":"2004","unstructured":"Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, Ellerby LM. Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus. J Biol Chem, 2004, 279: 20211-20220.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"Lunkes A","year":"2002","unstructured":"Lunkes A, Lindenberg KS, Ben Haiem L, Weber C, Devys D, Landwehrmeyer GB, Mandel JL. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell, 2002, 10: 259-269.","journal-title":"Mol Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","volume":"22","author":"Wellington CL","year":"2002","unstructured":"Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK, Loubser O. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci, 2002, 22: 7862-7872.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/318207","volume":"68","author":"Leavitt BR","year":"2001","unstructured":"Leavitt BR, Guttman JA, Hodgson JG, Kimel GH, Singaraja R, Vogl AW, Hayden MR. Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am J Hum Genet, 2001, 68: 313-324.","journal-title":"Am J Hum Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"Rigamonti D","year":"2000","unstructured":"Rigamonti D, Bauer JH, De Fraja C, Conti L, Sipione S, Sciorati C, Clementi E. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci, 2000, 20: 3705-3713.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"Zuccato C","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science, 2001, 293: 493-498.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","volume":"7","author":"Cooper JK","year":"1998","unstructured":"Cooper JK, Schilling G, Peters MF, Herring WJ, Sharp AH, Kaminsky Z, Masone J. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet, 1998, 7: 783-790.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","volume":"141","author":"Hackam AS","year":"1998","unstructured":"Hackam AS, Singaraja R, Wellington CL, Metzler M, McCutcheon K, Zhang T, Kalchman M. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J Cell Biol, 1998, 141: 1097-1105.","journal-title":"J Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","volume":"18","author":"Martindale D","year":"1998","unstructured":"Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, Mc-Cutcheon K, Singaraja R. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet, 1998, 18: 150-154.","journal-title":"Nat Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"Saudou F","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 1998, 95: 55-66.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1745-7254.2006.00410.x","volume":"27","author":"Wang LH","year":"2006","unstructured":"Wang LH, Qin ZH. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacol Sin, 2006, 27: 1287-1302.","journal-title":"Acta Pharmacol Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","volume":"63","author":"Murer MG","year":"2001","unstructured":"Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol, 2001, 63: 71-124.","journal-title":"Prog Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"Ferrer I","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ritalta T. Brain-derived neurotrophic factor in Huntington disease. Brain Res, 2000, 866: 257-261.","journal-title":"Brain Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"Zuccato C","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet, 2003, 35: 76-83.","journal-title":"Nat Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","volume":"11","author":"Hermel E","year":"2004","unstructured":"Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ, 2004, 11: 424-438.","journal-title":"Cell Death Differ"},{"key":"null","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"Zuccato C","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M. Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res, 2005, 52: 133-139.","journal-title":"Pharmacol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"Sugars KL","year":"2003","unstructured":"Sugars KL, Rubinsztein DC. Transcriptional abnormalities in Huntington disease. Trends Genet, 2003, 19: 233-238.","journal-title":"Trends Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","volume":"279","author":"Sugars KL","year":"2004","unstructured":"Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem, 2004, 279: 4988-4999.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","volume":"30","author":"Cong SY","year":"2005","unstructured":"Cong SY, Pepers BA, Evert BO, Rubinsztein DC, Roos RA, van Ommen GJ, Dorsman JC. Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci, 2005, 30: 12-23.","journal-title":"Mol Cell Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1471-4159.2002.01096.x","volume":"83","author":"Takeuchi Y","year":"2002","unstructured":"Takeuchi Y, Miyamoto E, Fukunaga K. Analysis on the promoter region of exon IV brain-derived neurotrophic factor in NG108-15 cells. J Neurochem, 2002, 83: 67-79.","journal-title":"J Neurochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"Dunah AW","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 2002, 296: 2238-2243.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"Li SH","year":"2002","unstructured":"Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol, 2002, 22: 1277-1287.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1523\/JNEUROSCI.20-21-08012.2000","volume":"20","author":"Blondel O","year":"2000","unstructured":"Blondel O, Collin C, McCarran WJ, Zhu S, Zamostiano R, Gozes I, Brenneman DE. A glia-derived signal regulating neuronal differentiation. J Neurosci, 2000, 20: 8012-8020.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.it.2007.01.005","volume":"28","author":"Farina C","year":"2007","unstructured":"Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol, 2007, 28: 138-145.","journal-title":"Trends Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1471-4159.2004.02420.x","volume":"89","author":"Liberto CM","year":"2004","unstructured":"Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokineactivated astrocytes. J Neurochem, 2004, 89: 1092-1100.","journal-title":"J Neurochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0188-4409(01)00316-2","volume":"32","author":"Maccioni RB","year":"2001","unstructured":"Maccioni RB, Munoz JP, Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res, 2001, 32: 367-381.","journal-title":"Arch Med Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","volume":"28","author":"Chou SY","year":"2008","unstructured":"Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH, Dickson DW. Expanded polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes. J Neurosci, 2008, 28: 3277-3290.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/abbs\/gmp021","volume":"41","author":"Wang LH","year":"2009","unstructured":"Wang LH, Lin F, Wu JC, Qin ZH. High efficiency adenovirus-mediated expression of truncated N-terminal huntingtin fragment (htt552) in primary rat astrocytes. Acta Biochim Biophys Sin, 2009, 41: 325-334.","journal-title":"Acta Biochim Biophys Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"Livak KJ","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001, 25: 402-408.","journal-title":"Methods"},{"key":"null","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0896-6273(93)90335-O","volume":"10","author":"Timmusk T","year":"1993","unstructured":"Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron, 1993, 10: 475-489.","journal-title":"Neuron"},{"key":"null","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"Steffan JS","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 2001, 413: 739-743.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","volume":"17","author":"Warby SC","year":"2008","unstructured":"Warby SC, Doty CN, Graham RK, Carroll JB, Yang YZ, Singaraja RR, Overall CM. Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus. Hum Mol Genet, 2008, 17: 2390-2404.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"Graham RK","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell, 2006, 125: 1179-1191.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"Zuccato C","year":"2007","unstructured":"Zuccato C, Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol, 2007, 81: 294-330.","journal-title":"Prog Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0021-9258(19)88378-3","volume":"274","author":"Timmusk T","year":"1999","unstructured":"Timmusk T, Palm K, Lendahl U, Metsis M. Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J Biol Chem, 1999, 274: 1078-1084.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2010.02.003","volume":"39","author":"Buckley NJ","year":"2010","unstructured":"Buckley NJ, Johnson R, Zuccato C, Bithell A, Cattaneo E. The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiol Dis, 2010, 39: 28-39.","journal-title":"Neurobiol Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"McCampbell A","year":"2000","unstructured":"McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, Walcott J, Merry D. CREB binding protein sequestration by expanded polyglutamine. Hum Mol Genet, 2000, 9: 2197-2202.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"Nucifora FC","year":"2001","unstructured":"Nucifora FC, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science, 2001, 291: 2423-2428.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","volume":"11","author":"Yu ZX","year":"2002","unstructured":"Yu ZX, Li SH, Nguyen HP, Li XJ. Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet, 2002, 11: 905-914.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","volume":"22","author":"Chen-Plotkin AS","year":"2006","unstructured":"Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE, DiRocco DP. Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis, 2006, 22: 233-241.","journal-title":"Neurobiol Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"Lievens JC","year":"2001","unstructured":"Lievens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L, Bates GP. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis, 2001, 8: 807-821.","journal-title":"Neurobiol Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/hmg\/ddi067","volume":"14","author":"Lievens JC","year":"2005","unstructured":"Lievens JC, Rival T, Iche M, Chneiweiss H, Birman S. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet, 2005, 14: 713-724.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"Shin JY","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol, 2005, 171: 1001-1012.","journal-title":"J Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","volume":"19","author":"Batchelor PE","year":"1999","unstructured":"Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci, 1999, 19: 1708-1716.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"10352","DOI":"10.1073\/pnas.88.22.10352","volume":"88","author":"Ceccatelli S","year":"1991","unstructured":"Ceccatelli S, Ernfors P, Villar MJ, Persson H, H\u00f6kfelt T. Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci USA, 1991, 88: 10352-10356.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/047518467CE94D118B927186FBA3B539","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmr125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/047518467CE94D118B927186FBA3B539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:52:31Z","timestamp":1686660751000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmr125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,1]]},"published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmr125","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}